title: An in situ oxidation strategy towards overcoming hERG affinity.
authors.affiliation: Worldwide Medicinal Chemistry, Pfizer Global Research and Development, Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom. david.pryde@pfizer.com
authors.forename: David C
authors.initials: DC
authors.lastname: Pryde
authors.forename: Rhys
authors.initials: R
authors.lastname: Jones
authors.forename: Donald S
authors.initials: DS
authors.lastname: Middleton
authors.forename: Ben J
authors.initials: BJ
authors.lastname: Laverty
authors.forename: David R
authors.initials: DR
authors.lastname: Fenwick
authors.forename: Helen J
authors.initials: HJ
authors.lastname: Mason
authors.forename: Martin
authors.initials: M
authors.lastname: Corless
authors.forename: Nick N
authors.initials: NN
authors.lastname: Smith